Among these enzymes, over-expression of Dnmt3b have been found in the tumor tissues of approximately 30% of breast cancer patients, whereas Dnmt1 and Dnmt3b are over-expressed in approximately 5% and 3% of breast tumors [27]. Here, DNMT3B is linked to breast neoplasm.